Donate
  • Freedom
  • Innovation
  • Growth

Merrill Matthews

Resident Scholar

Merrill Matthews, Ph.D., is a resident scholar with the Institute for Policy Innovation, a research-based, public policy “think tank.” He is a health policy expert and opinion contributor at The Hill. He also serves on the Texas Advisory Committee of the U.S. Commission on Civil Rights.

Dr. Matthews is a past president of the Health Economics Roundtable for the National Association for Business Economics, the largest trade association of business economists. Dr. Matthews also served for 10 years as the medical ethicist for the University of Texas Southwestern Medical Center’s Institutional Review Board for Human Experimentation, co-author of On the Edge: America Faces the Entitlements Cliff, and has contributed chapters to several books, including Physician Assisted SuicideExpanding the Debate and The 21st Century Health Care Leader and Stop Paying the Crooks (on Medicare fraud).  

He has been published in numerous journals and newspapers, including The Wall Street Journal, Investor’s Business Daily, Barron’s, USA Today, Forbes magazine and the Washington Times.  He was an award-winning political analyst for the USA Radio Network. 

Dr. Matthews received his Ph.D. in Humanities from the University of Texas at Dallas.

June 26, 2012

The Supreme Court's Decision Won't Affect the Real Health Care Revolution

Real health care reform is happening, not in Congress or the Supreme Court, but in the eHealth explosion.

June 22, 2012

How ObamaCare Increases Income Inequality

Income inequality appears to be growing in the United States.  And while President Obama didn’t initiate the trend, his health care legislation will dramatically exacerbate it.

June 21, 2012

Matthews Available for Coverage of Supreme Court Health Care Law Decision

Dr. Merrill Matthews, IPI health care expert, is available for interview to offer analysis throughout ongoing coverage of the historic Supreme Court decision regarding the Patient Protection and Affordable Care Act, expected next week.

June 20, 2012

There's a Triple Tax Increase in Your Future

The so-called Bush tax cuts are set to expire at the end of the year. That means that all of the current income tax rates will rise to pre-2001 levels overnight. But there's more. The health care law imposes a new 3.8% tax on passive income, including dividends and interest. So the effective dividend tax rate for those at the upper end of the income scale would nearly triple, to 43.4%. Happy New Year!

June 19, 2012

One Health Insurance CEO Now Opposes the Mandate; Too Late

Had the health insurers stood up for free market principles and defended long-held actuarial principles for underwriting risk, the country might have avoided the ObamaCare nightmare.

June 14, 2012

Obama Denies Being The 'Regulation President'; He's Wrong

President Obama denies regulations have grown during his tenure, even as he and his administration have pushed for a massive regulatory expansion in the health care, financial and energy industries.

June 12, 2012

Who Are the Rich and How Do We Know?

While we all may agree that certain people are rich, determining where to draw the line-and what should be included in the calculation-is both difficult and arbitrary.

June 8, 2012

Some Republicans Embrace ObamaCare Mandates

Some Republicans apparently want to retain some ObamaCare provisions because they're popular, which would force them to be as heavy handed as the Democrats have been.

June 5, 2012

How to Eliminate Counterfeit Prescription Drugs in the US

Counterfeits are here and will only grow unless Congress and the U.S. Food and Drug Administration (FDA) devise a better way to monitor prescription drugs from inception to ingestion. Fortunately, the latest version of the Prescription Drug User Fee Act, referred to as PDUFA V, has passed Congress and includes a “placeholder,” which allows Congress to figure out the best way to track prescription drugs as they move through the supply chain to the patient.

June 5, 2012

We Can Eliminate Counterfeit Drugs in the U.S. Supply Chain

Counterfeit drugs are here and will only grow unless Congress and the FDA devise a better way to monitor prescription drugs from inception to ingestion.

Total Records: 1735